tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

TG Therapeutics raises FY25 global revenue to $585M from $575M

FY25 revenue consensus $587.53M. Raises BRIUMVI U.S. net product revenue target to $570 – $575 million for the full year 2025, prior guidance of $560 million for full year 2025

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1